Search Results 1 – 20 of 20
What’s New in the COVID-19 and HIV Guidance
Guidance for COVID-19 and People with HIV
Appendix B: Drug Characteristics Tables
Limitations to Treatment Safety and Efficacy
Considerations for Antiretroviral Use in Patients with Coinfections
Appendix A: Key to Acronyms
Laboratory Testing
Management of the Treatment-Experienced Patient
Drug-Drug Interactions
Introduction
Special Patient Populations
What Not to Use
Financial Disclosure
What to Start: Initial Combination Regimens for the Antiretroviral-Naive Patient
Treatment Goals
Panel Roster
Initiation of Antiretroviral Therapy
What's New in the Guidelines
Baseline Evaluation
Antiretroviral Therapy to Prevent Sexual Transmission of HIV (Treatment as Prevention)